Radiographic spine fusion assessment is complicated by a lack of standardized criteria, highlighting the need for imaging expertise during clinical trials.
The latest news regarding the 1st AI Platform to look at the dynamic nature of x-rays.
How does AI-powered Clinical Decision Support Software provide utility to the spine surgeon?
SpineCAMP can provide Actionable Insights related to spinal instability or fusion assessment!
A provocative discussion among spinal clinicians, researchers, biomechanicians, and technology engineers regarding the state of spinal diagnostics.
Featuring MMI’s John Hipp, PhD, along with Zorica Buser, PhD, and Charles Reitman, MD.
In a research letter in Spine, MMI collaborated with researchers to investigate the SPSI as an objective measure of instability in lumbar stenosis patients with degenerative spondylolisthesis.
Stop by to learn how SpineCAMP uses AI to analyze X-rays to generate enhanced visualizations & reports, to support clinical assessment of spine health.
https://tech.einnews.com/pr_news/659012865/medical-metrics-inc-hires-dennis-farrell-to-lead-commercialization-of-spinecamp-ai-powered-image-analysis-platform
https://www.einpresswire.com/article/656086444/medical-metrics-inc-announces-latest-510-k-clearance-for-spine-camp-ai-powered-image-analysis-platform
Since 2000, the FDA has explicitly described the importance of radiographic evaluation in spinal studies in primary and secondary endpoints.
The FDA granted RMAT designation to DiscGenics’ Injectable Disc Cell Therapy for degenerative disc disease.
